You are viewing the site in preview mode

Skip to main content

Advertisement

Table 2 STI-related health care, coverage of hepatitis A/B vaccination, screening for STIs, diagnosed STIs, and partner notification in two sub-samples of MSM in Germany: n (%); results for lifetime and the previous 12 months

From: Self-reported history of sexually transmissible infections (STIs) and STI-related utilization of the German health care system by men who have sex with men: data from a large convenience sample

  Last HIV test negative or not tested for HIV n = 3,511 HIV-positive n = 874 OR (95%-CI)/p
STI-related health care
Preferred STI care provider      <0.001 (χ2)
   General Practitioner 1,637 (46.6) 448 (51.3)  
   Dermatologist 590 (16.8) 243 (27.8)  
   Urologist 808 (23.0) 118 (13.5)  
   Public Health office 475 (13.5) 55 (6.3)  
Low threshold testing* 2,806 (79.9) 527 (60.3) 0.38 (0.33-0.45)
Would prefer a gay physician 2,529 (72.0) 614 (70.3) 0.92 (0.78-1.08)
Communication barriers** 1,589 (45.3) 180(20.6) 0.31 (0.26-0.37)
  Last 12 m. Lifetime Last 12 m. Lifetime  
Medical consultation for STIs 757 (21.6)   433 (49.5)   3.57 (3.06-4.17)
   1,327 (37.8)   597 (68.3) 3.55 (3.03-4.15)
No medical consultation*** 190 (5.4)   28 (3.2)   0.58 (0.39-0.87)
Hepatitis A vaccination   1,932 (55.0)   566 (64.8) 1.50 (1.23-1.75)
Hepatitis B vaccination   2,045 (58.8)   577 (66.0) 1.39 (1.19-1.63)
Self-reported testing/screening §
  Last 12 m. Lifetime Last 12 m. Lifetime  
HIV 888 (25.3)§§ 2,367 (67.4) 183 (20.9)§§ n.a. n.a.
HCV 787 (22.4)   437 (50.0)   3.46 (2.97-4.04)
   1,223 (34.8)   577 (66.0) 3.64 (3.11-4.25)
Chlamydia 264 (7.5)   220 (25.2)   4.14 (3.40-5.04)
   415 (11.8)   300 (34.4) 3.90 (3.28-4.64)
Syphilis 556 (15.8)   472 (54.0)   6.24 (5.31-7.33)
   799 (22.8)   584 (66.8) 6.84 (5.82-8.03)
Gonorrhoea (rectal) 240 (6.8)   177 (20.3)   3.46 (2.90-4.27)
   352 (10.0)   248 (28.4) 3.56 (2.96-4.27)
Gonorrhoea (pharyngeal) 232 (6.6)   159 (18.2)   3.14 (2.53-3.91)
   330 (9.4)   223 (25.5) 3.30 (2.73-3.99)
Any of the above (not HIV) 992 (28.3)   572 (65.4)   4.81 (4.11-5.63)
   1,522 (43.3)   713 (81.6) 5.79 (4.82-6.95)
Self-reported diagnoses
  Last 12 m. Lifetime Last 12 m. Lifetime  
HCV 13 (0.4)   38 (4.3)   12.23 (6.49-23.06)
   29 (0.8)   77 (8.8) 11.60 (7.52-17.90)
Chlamydia 66 (1.9)   104 (11.9)   7.05 (5.13-9.69)
   199 (5.7)   233 (26.7) 6.05 (4.92-7.44)
Syphilis 84 (2.4)   138 (15.8)   7.65 (5.77-10.15)
   232 (6.6)   366 (41.9) 10.18 (8.43-12.30)
Gonorrhoea (urethral) 105 (3.0)   117 (13.4)   5.01 (3.81-6.60)
   459 (13.1)   357 (40.8) 4.59 (3.89-5.43)
Gonorrhoea (rectal) 28 (0.8)   39 (4.5)   5.81 (3.56-9.50)
   66 (1.9(   127 (14.5) 8.87 (6.52-12.07)
Gonorrhoea (pharyngeal) 12 (0.3)   17 (1.9)   5.78 (2.75-12.15)
   37 (1.1)   39 (4.5) 4.39 (2.78-6.92)
Any of the above (not HIV) 249 (7.1)   303 (34.7)   6.95 (5.75-8.40)
   745 (21.2)   616 (70.5) 8.87 (7.51-10.47)
Of those: Informed partner(s) 125 (50.2)   152 (50.2)   1.0 (0.71-1.39)
  1. *Low threshold testing: No general objection to testing campaigns in bars, discos, or saunas; **Communication barriers: Respondents who said the most important reason for not consulting a health care provider although suspecting to have acquired an STI was 'shame', or a feeling that talking about sex in general, or about sex with men, was not possible with their health care provider(s); *** No medical consultation: Proportion of respondents who said they did not consult a health care provider despite having symptoms or knowing that a sexual partner had an STI; § Self-reported testing/screening: Latest HIV antibody test; tested for STIs in the absence of specific symptoms? §§ Latest HIV test in 2005 or 2006 (i.e. within the previous 18 months); assuming that HIV-testing is equally spread over the year, this value was adjusted to 12 months